TRUSTMARK NATIONAL BANK TRUST DEPARTMENT - J P MORGAN EXCHANGE-TRADED F ownership

J P MORGAN EXCHANGE-TRADED F's ticker is JPST and the CUSIP is 46641Q837. A total of 896 filers reported holding J P MORGAN EXCHANGE-TRADED F in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
TRUSTMARK NATIONAL BANK TRUST DEPARTMENT ownership history of J P MORGAN EXCHANGE-TRADED F
ValueSharesWeighting
Q3 2023$34,581,145
-3.0%
689,142
-3.1%
3.41%
+3.1%
Q2 2023$35,653,902
-3.6%
711,087
-3.3%
3.30%
-1.9%
Q1 2023$36,994,358
-7.1%
735,182
-7.4%
3.37%
-8.4%
Q4 2022$39,819,662
+22.6%
794,328
+22.7%
3.67%
+17.8%
Q3 2022$32,469,000
+0.4%
647,299
+0.3%
3.12%
+7.7%
Q2 2022$32,339,000
+12.4%
645,605
+12.8%
2.90%
+26.8%
Q1 2022$28,779,000
-23.5%
572,503
-23.1%
2.28%
-20.4%
Q4 2021$37,596,000
+0.5%
744,767
+1.0%
2.87%
-4.6%
Q3 2021$37,414,000
+47.8%
737,659
+47.9%
3.01%
+49.8%
Q2 2021$25,306,000
-9.6%
498,740
-9.5%
2.01%
-13.9%
Q1 2021$27,982,000
+8.7%
551,313
+8.8%
2.33%
-0.4%
Q4 2020$25,733,000
+10.5%
506,650
+10.5%
2.34%
+0.5%
Q3 2020$23,296,000
+1.3%
458,631
+1.1%
2.33%
-2.1%
Q2 2020$23,001,000
+54.3%
453,418
+51.1%
2.38%
+33.2%
Q1 2020$14,907,000
+0.1%
300,135
+1.7%
1.79%
+27.2%
Q4 2019$14,885,000
+503.1%
295,146
+503.1%
1.40%
+480.2%
Q3 2019$2,468,000
+486.2%
48,940
+485.7%
0.24%
+476.2%
Q2 2019$421,0008,3560.04%
Other shareholders
J P MORGAN EXCHANGE-TRADED F shareholders Q1 2023
NameSharesValueWeighting ↓
REDW Wealth LLC 1,415,002$71,429,00020.75%
Aspire Capital Advisors LLC 113,686$5,739,00019.17%
MASON STREET ADVISORS, LLC 493,250$24,899,00018.10%
SUN LIFE FINANCIAL INC 9,501,354$479,628,00017.80%
Cornerstone Management, Inc. 1,116,747$56,373,36615.56%
Paradigm Capital Management, LLC/NV 282,614$14,266,00014.18%
Pinion Investment Advisors, LLC 758,594$38,376,00014.08%
McCarthy Asset Management, Inc. 382,561$19,312,00013.28%
TERRIL BROTHERS, INC. 1,160,010$58,557,00012.87%
Paradigm, Strategies in Wealth Management, LLC 247,331$12,485,00012.65%
View complete list of J P MORGAN EXCHANGE-TRADED F shareholders